Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-30 @ 8:46 PM
Study NCT ID:
NCT06951334
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-30
First Post:
2025-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of Vildagliptin in Early Parkinson's Disease
Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Organization:
Study Overview
Official Title:
Clinical Trial of Vildagliptin in Early Parkinson's Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VERY-PD
Brief Summary:
Investigating the efficacy of Vildagliptin in delaying the progression of Parkinson's disease.
Detailed Description:
Exploring the effectiveness and safety of vildagliptin in delaying the progression of Parkinson's disease.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| FirstSunYetSen | OTHER | SunYetSen | View |